← Open Payments lookup

ABIGAIL SHOENFELT: Open Payments

NPI 1467803585 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,122 in 49 payments from 10 companies in 2025. Trend: 2023 $312 · 2024 $418 · 2025 $1,122

Food & beverage: $1,122
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.20$409
Axsome Therapeutics, Inc.2$141
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$104
E.R. Squibb & Sons, L.L.C.5$102
Vanda Pharmaceuticals Inc.3$88
Janssen Pharmaceuticals, Inc3$77
Alkermes, Inc.3$76
Teva Pharmaceuticals USA, Inc.3$64
Otsuka America Pharmaceutical, Inc.3$42
Luye Pharma (USA) Ltd.1$19

Products named: INGREZZA, Auvelity, CAPLYTA, COBENFY, FANAPT, INVEGA SUSTENNA, ARISTADA, AUSTEDO XR.

Industry payments across LA — which companies pay providers there.